Please login to the form below

Not currently logged in
Email:
Password:

ADHD

This page shows the latest ADHD news and features for those working in and with pharma, biotech and healthcare.

PMEA 2020: continuing to recognise excellence in improving patient outcomes

PMEA 2020: continuing to recognise excellence in improving patient outcomes

4. Award for Patient-Centricity. Sponsored by: Alexa Forbes Consulting Ltd. Winner: Stories That Never Stand Still: A Book Made for People with ADHD by People with ADHD by Takeda with ... 7. Excellence in Managing Established Products. Sponsored by:

Latest news

More from news
Approximately 15 fully matching, plus 124 partially matching documents found.

Latest Intelligence

  • Sourcing R&D innovation: why pharma companies need to evolve their business models Sourcing R&D innovation: why pharma companies need to evolve their business models

    With recent FDA approval of EndeavorRx by Akili, a ‘first of its kind attention treatment for children with ADHD delivered through a captivating video game experience’, and multiple innovative technologies in

  • Deal Watch March 2017 Deal Watch March 2017

    contingent payments for the ADHD company Neurovance; Shanghai Fosun paid $90m for a majority interest in Breas (see above); Ascendis Health paid R375m ($29m) for the Southern Africa operations of Cipla ... 320. Neurovance. Otsuka. Acquisition. Portfolio,

  • A rare talent A rare talent

    It allowed us to solidify our position as the world's largest rare disease company and we now are the leaders in haematology, lysosomal storage disorders with strong capabilities in ADHD

  • Challenging perceptions Challenging perceptions

    We try to be recognised as patient-centric by supporting and helping the overall ADHD community. ... Harnessing technology. Shire's communications efforts in ADHD have for some time included digital technology.

  • Pharma deals in February 2015 Pharma deals in February 2015

    in-house clinical and preclinical pipeline targeting serious diseases with blockbuster potential eg Alzheimer's disease, ADHD, metabolic disease, schizophrenia, migraine. ... Its initial development was focused on ADHD and other neurological diseases.

More from intelligence
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest appointments

  • Shire elects new chair Shire elects new chair

    During that time Shire has grown substantially, although has struggled in recent years with generic competition for big-selling attention deficit-hyperactivity disorder (ADHD) drug Adderall XR and plans to downsize

  • Bray Leino opens health and wellbeing PR practice Bray Leino opens health and wellbeing PR practice

    She has worked on campaigns for ADHD brands and public affairs for Shire Pharmaceuticals: cardiology products for AstraZeneca, Sanofi and Eli Lilly; mental health for Wyeth; diagnostics and devices for Roche

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Mednet Group Mednet Group

    For ADHD awareness month this year our Associate Medical Writer, Alex Teahan, has written a piece surrounding ADHD and employment. ... He discusses the advantages and disadvantages of ADHD at work, and areas of improvement for employers in supporting

  • PANDAS/PANS Awareness: A parent’s story

    As PANDAS is an autoimmune disease that leads to inflammation in the basal ganglia region of the brain, the symptoms (including head shakes, OCD, ADHD and vocal tics), tend to reappear

  • Neurodiversity, ADHD and work: Obstacles and opportunities

    2006). Characterizing cognition in ADHD: beyond executive dysfunction. Trends in cognitive sciences,  10(3), 117-123. ... 12. Hupfeld, K. E., Abagis, T. R., &Shah, P. (2018). Living “in the zone”: hyperfocus in adult ADHD. ADHD Attention Deficit

  • ADHD perspectives series

    The ADHD in practice editorial board looks to represent this multi-disciplinary team providing insight and opinion. ... ADHD community can work together to provide the personalised 'scaffolding' from their perspective.

More from PMHub
Approximately 2 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics